EUVIMEDEUVIMED entdecken
Crossref

Detection of colorectal cancer and advanced neoplasia during first surveillance interval after detection of adenomas in fecal immunochemical test cancer screening: a nationwide study

Pernille T Larsen iD, Susanne F Jørgensen iD, Rikke Hagemann-Madsen, Morten Rasmussen, Berit Andersen, Sisse H Njor iD

Endoscopy · 01.11.2024 · 56 (11) · 853-861

DOI: 10.1055/a-2343-5700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.11.2024. Verfasst von Pernille T Larsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Research Clinic for Cancer screening, Randers Regional Hospital, Randers NØ, Denmark. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma, Early Detection of Cancer, Occult Blood. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Harboefonden, Aage og Johanne Louis-Hansens Fond, Kræftens Bekæmpelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adenoma surveillance guidelines are based on non-fecal immunochemical test (FIT)-based screening settings. However, colorectal cancer (CRC) risk may be different in FIT-positive screening populations. We evaluated the CRC and advanced adenoma risk within the recommended surveillance periods in the Danish FIT-based CRC screening program for participants with intermediate or high risk adenomas according to 2010 European guidelines. Furthermore, we estimated CRC risk for those who were not recommended surveillance according to European Society of Gastrointestinal Endoscopy (ESGE) 2020 guidelines.

Methods

Using nationwide health registries, we identified 17 936 FIT-screening participants from 2014–2017 with adenomas undergoing surveillance (high risk 1 year, intermediate risk 3 years). Participants with a follow-up examination were included (N = 10 068). Relative risk (RR) of CRC and advance adenoma was compared between intermediate and high risk groups and between intermediates who were recommended surveillance (S) or no surveillance (NS) according to 2020 ESGE guidelines.

Results

During surveillance, CRC occurred in 0.59% of the high risk group and 1.11% of the intermediate risk group (RR 0.53 [95%CI 0.34–0.84]). The high risk group had a 24% increased risk of advanced adenoma. CRC occurred in 1.69% of the intermediateNS group and 0.87% of the intermediateS group (RR 1.94 [95%CI 1.18–3.21]), and RR for advanced adenoma was 1.19 (95%CI 1.03–1.37).

Conclusion

CRC detection was lower among participants rated at higher risk at initial CRC screening. Findings at first screen-derived colonoscopy might not be as good a predictor of CRC risk in a FIT-positive screening population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenomaEarly Detection of CancerOccult BloodColonoscopyHumansMaleFemaleMiddle AgedAgedDenmarkRegistriesRisk Assessment

Autor:innen und Institutionen

  • University Research Clinic for Cancer screening, Randers Regional Hospital, Randers NØ, Denmark.
  • Department of Clinical Medicine, Aarhus University Faculty of Health Sciences, Aarhus, Denmark.
  • Department of Data, Innovation and Research, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.
  • Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Pathology, Lillebaelt Hospital, Vejle, Denmark.
  • Digestive Disease Center, Bispebjerg Hospital, Copenhagen, Denmark.

ORCID-Profile: Pernille T Larsen, Susanne F Jørgensen, Sisse H Njor

Förderung

  • Harboefonden
  • Aage og Johanne Louis-Hansens Fond
  • Kræftens Bekæmpelse
  • Helsefonden

Zitieren

APA

Larsen, P. T., Jørgensen, S. F., Hagemann-Madsen, R., Rasmussen, M., Andersen, B., & Njor, S. H. (2024). Detection of colorectal cancer and advanced neoplasia during first surveillance interval after detection of adenomas in fecal immunochemical test cancer screening: a nationwide study. Endoscopy, 56(11), 853-861. https://doi.org/10.1055/a-2343-5700

Vancouver

Larsen PT, Jørgensen SF, Hagemann-Madsen R, Rasmussen M, Andersen B, Njor SH. Detection of colorectal cancer and advanced neoplasia during first surveillance interval after detection of adenomas in fecal immunochemical test cancer screening: a nationwide study. Endoscopy. 2024;56(11):853-861. doi:10.1055/a-2343-5700

BibTeX
@article{Larsen2024,
  author = {Larsen, Pernille T and Jørgensen, Susanne F and Hagemann-Madsen, Rikke and Rasmussen, Morten and Andersen, Berit and Njor, Sisse H},
  title = {Detection of colorectal cancer and advanced neoplasia during first surveillance interval after detection of adenomas in fecal immunochemical test cancer screening: a nationwide study},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {11},
  pages = {853--861},
  doi = {10.1055/a-2343-5700}
}
Kostenlos starten →